{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:15:35Z","timestamp":1773285335853,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Gynesonics Inc"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ejogrb.2018.03.053","type":"journal-article","created":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T03:42:22Z","timestamp":1522122142000},"page":"175-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Improvement in health utility after transcervical radiofrequency ablation of uterine fibroids with the sonata system: Health utility after radiofrequency ablation"],"prefix":"10.1016","volume":"224","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8248-2677","authenticated-orcid":false,"given":"Judith","family":"Huirne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"January (1)","key":"10.1016\/j.ejogrb.2018.03.053_bib0005","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"January (6)","key":"10.1016\/j.ejogrb.2018.03.053_bib0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/IJWH.S51083","article-title":"Uterine fibroids: current perspectives","volume":"29","author":"Khan","year":"2014","journal-title":"Int J Womens Health"},{"issue":"October (4)","key":"10.1016\/j.ejogrb.2018.03.053_bib0015","first-page":"433","article-title":"Uterine leiomyomata: etiology, symptomatology, and management","volume":"36","author":"Buttram","year":"1981","journal-title":"Fertil Steril"},{"issue":"May (1)","key":"10.1016\/j.ejogrb.2018.03.053_bib0020","first-page":"1503","article-title":"Uterine fibroid tumors: diagnosis and treatment","volume":"75","author":"Evans","year":"2007","journal-title":"Am Fam Phys"},{"issue":"March","key":"10.1016\/j.ejogrb.2018.03.053_bib0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1472-6874-12-6","article-title":"Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21, 746 women","volume":"12","author":"Zimmermann","year":"2012","journal-title":"BMC Womens Health"},{"issue":"September (1)","key":"10.1016\/j.ejogrb.2018.03.053_bib0030","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejogrb.2010.05.012","article-title":"The burden of uterine fibroids in five European countries","volume":"152","author":"Downes","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"September (7)","key":"10.1016\/j.ejogrb.2018.03.053_bib0035","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1089\/jwh.2006.15.818","article-title":"Uterine fibroids: a review of health-related quality of life assessment","volume":"15","author":"Williams","year":"2006","journal-title":"J Womens Health (Larchmt)"},{"issue":"October (4)","key":"10.1016\/j.ejogrb.2018.03.053_bib0040","first-page":"319","article-title":"The impact of uterine leiomyomas: a national survey of affected women","volume":"209","author":"Borah","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2018.03.053_bib0045","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10397-010-0655-3","article-title":"Transcervical, intrauterine ultrasound-guided radiofrequency ablation of uterine fibroids with VizAblate System: safety, tolerability, and ablation results in a closed abdomen setting","volume":"8","author":"Garza-Leal","year":"2011","journal-title":"Gynecol Surg"},{"issue":"October (10)","key":"10.1016\/j.ejogrb.2018.03.053_bib0050","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1007\/s00330-014-3295-6","article-title":"Volumetric MR-guided high-intensity focused ultrasound vesus uterine artery embolization for treatment of symptomatic uterine fibroids: comparison of symptom improvement and reintervention rates","volume":"24","author":"Ikink","year":"2014","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejogrb.2018.03.053_bib0055","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10397-014-0873-1","article-title":"Transcervical, intrauterine ultrasounded- guided radiofrequency ablation of uterine fibroids with the VizAblate\u00ae System: three- and six-month endpoint results from the FAST-EU study","volume":"12","author":"Bongers","year":"2015","journal-title":"Gynecol Surg"},{"key":"10.1016\/j.ejogrb.2018.03.053_bib0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10397-015-0915-3","article-title":"The FAST-EU trial: 12-month clinical outcomes of women after intrauterine sonography-guided transcervical radiofrequency ablation of uterine fibroids","volume":"13","author":"Br\u00f6lmann","year":"2016","journal-title":"Gynecol Surg"},{"issue":"September (9746)","key":"10.1016\/j.ejogrb.2018.03.053_bib0065","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S0140-6736(10)61386-4","article-title":"Innovation or regulation: IDEAL opportunity for consensus","volume":"376","author":"McCulloch","year":"2010","journal-title":"Lancet"},{"issue":"April (1)","key":"10.1016\/j.ejogrb.2018.03.053_bib0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijgo.2010.11.011","article-title":"FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age","volume":"113","author":"Munro","year":"2011","journal-title":"Int J Gynaelcol Obstet"},{"key":"10.1016\/j.ejogrb.2018.03.053_bib0075","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1471-0528.1990.tb16249.x","article-title":"Assessment of menstrual blood loss using a pictorial chart","volume":"97","author":"Higham","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2018.03.053_bib0080","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0015-0282(01)01847-7","article-title":"Determination of total menstrual blood loss","volume":"76","author":"Wyatt","year":"2001","journal-title":"Fertil Steril"},{"issue":"February (2)","key":"10.1016\/j.ejogrb.2018.03.053_bib0085","first-page":"290","article-title":"The UFS-QOL, a new disease- specific symptom and health-related quality of life questionnaire for leiomyomata","volume":"99","author":"Spies","year":"2002","journal-title":"Obstet Gynecol"},{"issue":"December (3)","key":"10.1016\/j.ejogrb.2018.03.053_bib0090","first-page":"199","article-title":"EuroQol \u2013a new facility for the measurement of health-related quality of life","volume":"16","author":"EuroQol Group","year":"1990","journal-title":"Health Policy"},{"issue":"July (1)","key":"10.1016\/j.ejogrb.2018.03.053_bib0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","article-title":"EuroQol;1;: the current state of play","volume":"37","author":"Brooks","year":"1996","journal-title":"Health Policy"},{"issue":"January (6719)","key":"10.1016\/j.ejogrb.2018.03.053_bib0100","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/bmj.300.6719.230","article-title":"Analysis of serial measurements in medical research","volume":"300","author":"Matthews","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2018.03.053_bib0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/bmb\/ldq033","article-title":"Health outcomes in economic evaluation: the QALY and utilities","volume":"96","author":"Whitehead","year":"2010","journal-title":"Br Med Bull"},{"issue":"April (4)","key":"10.1016\/j.ejogrb.2018.03.053_bib0110","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s40273-014-0136-z","article-title":"Estimating QALY gains in applied studies: a review of cost-utility analyses published in 2010","volume":"32","author":"Wisl\u00f8ff","year":"2014","journal-title":"Pharmacoeconomics"},{"issue":"March (3)","key":"10.1016\/j.ejogrb.2018.03.053_bib0115","doi-asserted-by":"crossref","first-page":"e91891","DOI":"10.1371\/journal.pone.0091891","article-title":"Levonorgestrel-releasing intrauterine system vs. usual medical treatment for menorrhagia: an economic evaluation alongside a randomized controlled trial","volume":"9","author":"Sanghera","year":"2014","journal-title":"PLoS One"},{"issue":"May (5)","key":"10.1016\/j.ejogrb.2018.03.053_bib0120","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/rheumatology\/36.5.551","article-title":"Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D)","volume":"36","author":"Hurst","year":"1997","journal-title":"Br J Rheumatol"},{"issue":"July (8)","key":"10.1016\/j.ejogrb.2018.03.053_bib0125","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1471-0528.2011.02952.x","article-title":"Randomised comparison of uterine artery embolization (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results","volume":"118","author":"Moss","year":"2011","journal-title":"BJOG"},{"issue":"November (5)","key":"10.1016\/j.ejogrb.2018.03.053_bib0130","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.ajog.2005.05.017","article-title":"Uterine artery embolization vs. hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): peri- and postprocedural results from a randomized controlled trial","volume":"193","author":"Hehenkamp","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2018.03.053_bib0135","series-title":"EQ-5D Value Sets","author":"Szende","year":"2007"},{"issue":"February (2)","key":"10.1016\/j.ejogrb.2018.03.053_bib0140","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.fertnstert.2007.11.078","article-title":"Uterine artery embolization, hysterectomy, or myomectomy for symptomatic uterine fibroids: a cost-utility analysis","volume":"91","author":"You","year":"2009","journal-title":"Fertil Steril"},{"issue":"June (3)","key":"10.1016\/j.ejogrb.2018.03.053_bib0145","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00270-011-0228-5","article-title":"Uterine artery embolization versus myomectomy: impact on quality of life \u2013results of the FUME (Fibroids of the Uterus: myomectomy versus Embolization) Trial","volume":"35","author":"Manyonda","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"January\u2013February (1)","key":"10.1016\/j.ejogrb.2018.03.053_bib0150","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00270-007-9195-2","article-title":"Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy","volume":"31","author":"Mara","year":"2008","journal-title":"Cardiovasc Intervent Radiol"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211518301519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211518301519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T19:30:09Z","timestamp":1721331009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211518301519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":30,"alternative-id":["S0301211518301519"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2018.03.053","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improvement in health utility after transcervical radiofrequency ablation of uterine fibroids with the sonata system: Health utility after radiofrequency ablation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2018.03.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}